Tocqueville Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,700
| Closed | -$222K | – | 530 |
|
|
2024
Q2 | $222K | Hold |
2,700
| – | – | ﹤0.01% | 489 |
|
|
2024
Q1 | $236K | Sell |
2,700
-100,000
| -97% | -$8.95M | ﹤0.01% | 485 |
|
|
2023
Q4 | $9.9M | Sell |
102,700
-26,665
| -21% | -$2.36M | 0.18% | 130 |
|
|
2023
Q3 | $11.4M | Buy |
129,365
+18,290
| +16% | +$1.63M | 0.22% | 122 |
|
|
2023
Q2 | $9.63M | Sell |
111,075
-16,945
| -13% | -$1.59M | 0.17% | 132 |
|
|
2023
Q1 | $12.4M | Sell |
128,020
-30
| -0% | -$3.11K | 0.24% | 117 |
|
|
2022
Q4 | $13.3M | Sell |
128,050
-35
| -0% | -$3.29K | 0.25% | 109 |
|
|
2022
Q3 | $10.9M | Sell |
128,085
-1,200
| -0.9% | -$107K | 0.22% | 113 |
|
|
2022
Q2 | $10.7M | Buy |
129,285
+860
| +0.7% | +$68.5K | 0.2% | 120 |
|
|
2022
Q1 | $9.9M | Sell |
128,425
-31,267
| -20% | -$2.62M | 0.15% | 157 |
|
|
2021
Q4 | $14.1M | Sell |
159,692
-90,360
| -36% | -$7.46M | 0.19% | 120 |
|
|
2021
Q3 | $19.3M | Buy |
250,052
+2,967
| +1% | +$234K | 0.29% | 93 |
|
|
2021
Q2 | $20.6M | Buy |
247,085
+11,138
| +5% | +$883K | 0.3% | 91 |
|
|
2021
Q1 | $17.8M | Buy |
235,947
+3,292
| +1% | +$269K | 0.27% | 100 |
|
|
2020
Q4 | $20.4M | Buy |
232,655
+7,135
| +3% | +$566K | 0.34% | 71 |
|
|
2020
Q3 | $17.2M | Buy |
+225,520
| New | +$22.8M | 0.33% | 77 |
|
|
2019
Q2 | – | Sell |
-85,725
| Closed | -$7.62M | – | 782 |
|
|
2019
Q1 | $7.62M | Buy |
85,725
+36
| +0% | +$3.34K | 0.1% | 216 |
|
|
2018
Q4 | $7.3M | Buy |
85,689
+219
| +0.3% | +$20.8K | 0.11% | 203 |
|
|
2018
Q3 | $8.29M | Buy |
85,470
+1,035
| +1% | +$103K | 0.1% | 213 |
|
|
2018
Q2 | $7.95M | Sell |
84,435
-2,050
| -2% | -$180K | 0.1% | 216 |
|
|
2018
Q1 | $7.01M | Buy |
+86,485
| New | +$7.42M | 0.09% | 233 |
|
|
2017
Q3 | – | Sell |
-19,250
| Closed | -$1.75M | – | 815 |
|
|
2017
Q2 | $1.75M | Sell |
19,250
-1,850
| -9% | -$168K | 0.02% | 438 |
|
|
2017
Q1 | $1.85M | Buy |
21,100
+18,600
| +744% | +$1.65M | 0.02% | 427 |
|
|
2016
Q4 | $207K | Sell |
2,500
-42,275
| -94% | -$3.64M | ﹤0.01% | 760 |
|
|
2016
Q3 | $4.14M | Sell |
44,775
-10,570
| -19% | -$995K | 0.05% | 315 |
|
|
2016
Q2 | $4.31M | Sell |
55,345
-1,630
| -3% | -$139K | 0.05% | 311 |
|
|
2016
Q1 | $4.7M | Buy |
56,975
+500
| +0.9% | +$40.7K | 0.06% | 287 |
|
|
2015
Q4 | $5.92M | Sell |
56,475
-2,820
| -5% | -$294K | 0.08% | 249 |
|
|
2015
Q3 | $6.25M | Buy |
59,295
+1,115
| +2% | +$149K | 0.08% | 259 |
|
|
2015
Q2 | $7.96M | Buy |
58,180
+42,045
| +261% | +$5.21M | 0.09% | 237 |
|
|
2015
Q1 | $2.01M | Hold |
16,135
| – | – | 0.02% | 477 |
|
|
2014
Q4 | $1.46M | Buy |
16,135
+1,000
| +7% | +$83.2K | 0.02% | 520 |
|
|
2014
Q3 | $1.09M | Sell |
15,135
-1,200
| -7% | -$78.9K | 0.01% | 495 |
|
|
2014
Q2 | $1.02M | Buy |
16,335
+100
| +0.6% | +$6.04K | 0.01% | 571 |
|
|
2014
Q1 | $1.11M | Hold |
16,235
| – | – | 0.01% | 435 |
|
|
2013
Q4 | $1.14M | Sell |
16,235
-1,500
| -8% | -$102K | 0.02% | 431 |
|
|
2013
Q3 | $1.28M | Sell |
17,735
-700
| -4% | -$46.5K | 0.02% | 479 |
|
|
2013
Q2 | $1.03M | Buy |
+18,435
| New | +$1.15M | 0.01% | 495 |
|
Other funds holding BMRN
EIM